Search

866-361-3032

Dec. 7 - FDA Seeks Input on Communication of Drug Safety Information

Posted Date: 
Wednesday, December 7, 2005
Body: 

As part of the Food and Drug Administration's continued commitment to improve communication about risks posed by prescription medications, its Center for Drug Evaluation and Research (CDER) is holding a public meeting today to evaluate current practices and to explore new tools and strategic partnerships to enhance future efforts.

"In the past year we have made significant strides in alerting healthcare professionals and their patients of emerging risks associated with prescription medications," said Andrew von Eschenbach, MD, Acting FDA Commissioner. "We intend to use the public feedback we receive at this meeting to advance our understanding of the effectiveness of our current efforts and to develop new tools to hone our ability to inform the public."

Source

Testimonial

Nexreg provided prompt and professional service when we needed rapid turn-around time on an MSDS. Nexreg was very easy to deal with and provided guidance throughout the process and always responded immediately to any questions we had.
Jill Hamilton, Verla International LTD.